4 Takeaways from Sen. Johnson’s Panel on COVID-19 Vaccines

QUOTE: Sen. Ron Johnson (R-Wis.) held a panel on COVID-19 vaccines in Washington on Dec. 7, featuring experts including Dr. Robert Malone and Dr. Peter

McCullough.Experts discussed vaccine development, vaccine composition, data from insurance and adverse event systems, and other topics. Here are four takeaways from the panel.

Insurance Experts Record Jump in Excess Mortality

Edward Dowd, a former BlackRock analyst now with the Humanity Project, showed data from the Society of Actuaries 2021 Group Life Insurance survey that showed a jump in excess mortality among young and middle-aged adults starting around the time the vaccines began being administered.

Doctors Report Increase in Heart Inflammation Since Pandemic Started

Several vaccines have been linked to side effects such as myocarditis, a form of heart inflammation that can turn deadly.Doctors testifying during the panel said they’ve seen an increase in patients with the inflammation.”It’s been very high,” Dr. Reneta Moon, a clinical associate professor at the Washington State University College of Medicine.

Young People at Little Risk From COVID-19

Dr. Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, presented data from the CDC that show young people face little risk from COVID-19.The share of infection among those aged 0 to 17 that led to death, for instance, was just 0.01 percent through September 2021, while the share was 0.05 percent among those 18 to 29.

No Strong Trials

Dr. McCullough, chief scientific officer of The Wellness Company, said that no randomized, double-blind, placebo-controlled trial has shown the vaccines reduce hospitalization or death.

https://www.theepochtimes.com/4-takeaways-from-sen-johnsons-panel-on-covid-19-vaccines_4910155.html?utm_medium=Social&utm_source=gettr

Not Even N95 Masks Work To Stop Covid

QUOTE: There is new research that has been released showing that masks are ineffective, regardless of type.

And it’s not just new research, it’s high quality research.

The Annals of Internal Medicine just published a randomized controlled trial comparing the ability of medical masks to prevent COVID infection to fit-tested N95s.

Importantly, this trial was conducted on healthcare workers who would be most likely to use masks appropriately.

That trial design was also important as it was meant to determine whether or not N95 respirators were superior to “regular” surgical masks.

They examined 29 different health care facilities on multiple continents, from North America to Asia and Africa.

The percentage of healthcare workers testing positive for COVID in each group was tracked to determine how effective or ineffective higher-quality masking was in preventing infection.

Unsurprisingly, the results confirmed that there is essentially zero difference between surgical or N95 respirators when it comes to tests results.No matter how “high quality” your mask is, it’s entirely irrelevant.

The researchers also took pains to ensure that the control and treatment groups shared as many similarities as possible.

Yet none of that mattered; there was no difference in outcomes between the medical and N95 level masks.

Even more importantly, these disappointing results were from facilities with universal masking policies in place.

This is yet another randomized controlled trial to show that masks do not work. If “The Experts™” actually cared about following “the science,” or “the evidence,” this would once again be the nail in the coffin for masking. More like the 40th nail in the coffin.